M. Michelle Berrey - 14 Sep 2023 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
President, R&D & CMO
Signature
/s/ Rocco Venezia, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
14 Sep 2023
Net transactions value
-$14,416
Form type
4
Filing time
18 Sep 2023, 16:01:14 UTC
Previous filing
16 Jun 2023
Next filing
13 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $14,416 -1,246 -1.5% $11.57 80,139 14 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.